Current regulatory arrangements for assisted conception treatment in European countries

Gianaroli, Luca; Ferraretti, Anna Pia; Magli, Maria Cristina; Sgargi, Serena

doi:10.1016/j.ejogrb.2016.10.002

Cited by 24 publications

(13 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the USA, high costs have generated 'reproductive tourism' to countries with lower fees but also with safety concerns (31). In many European countries, there are programmes for public funding but with considerable variations in the number of cycles that are funded, age limits, and the proportion of the total cost that is paid for, among other factors (29,32). Public funding is often restricted to IVF performed in public hospitals and clinics (29).…”

Section: The Cost-effectiveness Principlementioning

confidence: 99%

Use ofin vitrofertilization—ethical issues

Asplund

2019

Upsala Journal of Medical Sciences

View full text Add to dashboard Cite

This report is an ethical analysis based on both facts and values. In in vitro fertilization (IVF), there is an intricate interaction between rapid scientific development and changing societal values. In most countries, the ethical discussion is no longer on whether or not IVF in itself is ethically justifiable. Therefore, in this review, I discuss other ethical aspects that have emerged since IVF was first introduced, such as upper age limits, 'ownership' of gametes and embryos, IVF in single women and samesex couples, preimplantatory genetic testing, social egg freezing, commercialization, public funding, and prioritization of IVF. Despite secularization, since religion still plays an important role in regulation and practices of IVF in many countries, positions on IVF among the world religions are summarized. Decision-making concerning IVF cannot be based only on clinical and economic considerations; these cannot be disentangled from ethical principles. Many concerns regarding the costs, effects, and safety of IVF subtly transcend into more complex questions about what it means to society to bear and give birth to children.

show abstract

Section: The Cost-effectiveness Principlementioning

confidence: 99%

Use ofin vitrofertilization—ethical issues

Asplund

2019

Upsala Journal of Medical Sciences

View full text Add to dashboard Cite

show abstract

“…the United Kingdom, the Netherlands and Spain) and usually restricted to heterosexual couples. Moreover, the state only subsidises IVF with donor gametes in a few countries (Gianaroli et al 2016 ).…”

Section: Introduction: Genetic Diseases Genome Editing and Existing mentioning

confidence: 99%

“…PGD allows the testing of embryos created with IVF for genetic abnormalities prior to their transfer in utero. This technology is currently legal in many European countries (Gianaroli et al 2016 ), but in some countries it remains restricted to so-called ‘serious’ conditions (e.g. in Italy and Germany), and in others is completely banned (e.g.…”

Section: Introduction: Genetic Diseases Genome Editing and Existing mentioning

confidence: 99%

See 1 more Smart Citation

Genome editing and assisted reproduction: curing embryos, society or prospective parents?

Cavaliere

2017

Med Health Care and Philos

View full text Add to dashboard Cite

This paper explores the ethics of introducing genome-editing technologies as a new reproductive option. In particular, it focuses on whether genome editing can be considered a morally valuable alternative to preimplantation genetic diagnosis (PGD). Two arguments against the use of genome editing in reproduction are analysed, namely safety concerns and germline modification. These arguments are then contrasted with arguments in favour of genome editing, in particular with the argument of the child’s welfare and the argument of parental reproductive autonomy. In addition to these two arguments, genome editing could be considered as a worthy alternative to PGD as it may not be subjected to some of the moral critiques moved against this technology. Even if these arguments offer sound reasons in favour of introducing genome editing as a new reproductive option, I conclude that these benefits should be balanced against other considerations. More specifically, I maintain that concerns regarding the equality of access to assisted reproduction and the allocation of scarce resources should be addressed prior to the adoption of genome editing as a new reproductive option.

show abstract

“…The key element in this respect is the final number of donors accepted, because they are essential to the viability of the bank. Despite the existence of Europe-wide regulations in this field, the presence of national regulations, too, means that the practise of gamete donation varies greatly among EU countries (1). Taking into account the donor motivation findings reported by Pennings et al (2), in a study of oocyte donors in different European countries, we conclude that oocyte donation is motivated by two crucial elements: economic and altruistic reasons.…”

mentioning

confidence: 98%

Sperm and oocyte bank set-up

Jose¹

2017

CCE

View full text Add to dashboard Cite

Current regulatory arrangements for assisted conception treatment in European countries

Cited by 24 publications

References 9 publications

Use ofin vitrofertilization—ethical issues

Use ofin vitrofertilization—ethical issues

Genome editing and assisted reproduction: curing embryos, society or prospective parents?

Sperm and oocyte bank set-up

Contact Info

Product

Resources

About